Similarly, a pair of mouse cell lines with high (BW5147, TCL) and low (CT26, colon cancer) basal levels of RIPK3 expression were treated for 2 days with decitabine and levels of RIPK3 measured (Fig. 2A; Supplementary Fig. S11). This evidence concerns the gene RIPK3 and malignant colon neoplasm.